A relatively serene week in markets, which all closed in the green.
Congress made no progress yesterday on dealing with the nation's debt ceiling and budget plan as House Speak John Boehner canceled voting for his bill because a lack of support from Republicans.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
| Website: | www.curis.com |
| Email: | info@curis.com |
| Main Phone: | +1 617 503-6500 |
| Address: | 128 Spring Street |
| Address 2: | Building C - Suite 500 |
| State: | MA |
| City / Town: | Lexington |
| Country: | US |
| Postal Code: | 02421 |
| Exchange: | NSD |
| CEO: | James E. Dentzer |
| Employees: | 28 |
| NAICS: | Biological Product (except Diagnostic) Manufacturing(325414) |
A relatively serene week in markets, which all closed in the green.
Congress made no progress yesterday on dealing with the nation's debt ceiling and budget plan as House Speak John Boehner canceled voting for his bill because a lack of support from Republicans.
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
